Would you like to
contribute to this site?
IBS Menu
Submit an Article
Submit a Tip
Place your Ad
Add URL
IBS Questions?
Contact Us
Related Topics:
Ibs Treatment
Irritable Bowel Treatment
Treat Ibs
Treating Ibs
Treating Irritable Bowel
Treating Irritable Bowel Syndrome
Treat Irritable Bowel
Treat Irritable Bowel Syndrome
Treatment For Ibs
Treatment For Irritable Bowel
Treatment Of Ibs
Condition Ibs More Treatment
Copd Irritable Bowel Syndrome
Other Channels:
|
 |
|
|
|
|
|
|
|
|
Recent Questions and Answers
|
|
|
|
|
|
|
|
Recent Treatment Of Ibs News:
|
|
|
Ironwood Pharmaceuticals Inc. Posted on:29 Sep 11 Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced that its European partner Almirall, S.A. submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for linaclotide, a guanylate cyclase type-C (GC-C) agonist, for the treatment of irritable bowel syndrome with constipation (IBS-C).
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced that its European partner Almirall, S.A. submitted a Marketing Authorization Application ...
Ironwood Pharmaceuticals, Inc. today announced that its European partner Almirall, S.A. submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for linaclotide, a guanylate cyclase type-C (GC-C) agonist, for the treatment of irritable bowel syndrome with constipation.
Almirall, S.A. announced today that it has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for linaclotide, an investigational guanylate cyclase-C (GC-C) receptor agonist for the treatment of irritable bowel syndrome with constipation (IBS-C). Once approved, linaclotide will be marketed in Europe under the trademark Constella®.
MicroDose Therapeutx, Inc. today announced that the first human subject has been dosed in a Phase 1 clinical trial of MDT-637, MicroDose’s inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus .
|
|
| |
|
|
|
Additional Treatment Of Ibs Resources:
|
|
|
1.
Treatment options for IBS
You can help by giving your doctor as much information as possible on your symptoms and how they respond to treatment. Because IBS symptoms are chronic or
|
2.
IBS and Hypnosis
The results of the first formal research study(4) on hypnosis treatment for IBS were published in the Lancet in 1984. The investigators, Dr. Peter Whorwell
|
|
|
|
|
|
Want your site featured on this page?
|
|
|
|
